Behavioral effects of ketamine, an NMDA glutamatergic antagonist, in non-human primates

Psychopharmacology

Volumn 146, Issue 1, 1999, Pages 67-72

  Shiigi, Yasuyuki ^a,b,c   Casey, Daniel E ^a,b,d  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Research Laboratories   (Japan)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Behavior; Glutamate; Ketamine; NMDA; Non human primate

Indexed keywords

KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MENTAL DISEASE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; SCHIZOPHRENIA;

ANIMALS; BEHAVIOR, ANIMAL; CEBUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSTONIA; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; KETAMINE; MALE; MOTOR ACTIVITY; MOVEMENT DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SALIVATION;

EID: 0032847912     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051089     Document Type: Article

References (37)

1. Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate. Br J Pharmacol 79:565-575
2. Bakshi VP, Swerdlow NR, Geyer MA (1994) Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response. J Pharmacol Exp Ther 271:787-794
3. Balster RL, Chait LD (1976) The behavioral pharmacology of phencyclidine. Clin Toxicol 9:513-28
4. Byrd LD (1982) Comparison of the behavioral effects of phencyclidine, ketamine, d-amphetamine and morphine in the squirrel monkey. J Pharmacol Exp Ther 220:139-144
5. Casey DE (1996) Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys. Psychopharmacology 124:134-140
6. Casey DE, Gerlach J, Christensson E (1980) Dopamine, acetylcholine, and GABA effects in acute dystonia in primates. Psychopharmacology 70:83-87
7. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
8. Freed WJ, Bing LA, Wyatt RJ (1984) Effects of neuroleptics on phencyclidine (PCP)-induced locomotor stimulation in mice. Neuropharmacology 23:175-181
9. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology 129:79-84
10. Gunne LM, Barany S (1976) Haloperidol-induced tardive dyskinesia in monkeys. Psychopharmacology 50:237-240
11. Halberstadt AL (1995) The phencyclidine-glutamate model of schizophrenia. Clin Neuropharmacol 18:237-249
12. Hetzler BE, Wautlet BS (1985) Ketamine-induced locomotion in rats in an open-field. Pharmacol Biochem Behav 22:653-655
13. Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alteration of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399-407
14. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308
15. Jentsch JD, Redmond DE Jr, Elsworth JD, Taylor JR, Youngren KD, Roth RH (1997) Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277:953-955
16. Keith VA, Mansbach RS, Geyer MA (1991) Failure of haloperidol to block the effects of phencyclidine and dizocilpine on prepulse inhibition of startle. Biol Psychiatry 30:557-566
17. Kirn JS, Kornhuber HH, Schmid-Burgk W, Holzmuller B (1980) Low cerebrospinal fluid glutamate in schizophrenia patients and a new hypothesis on schizophrenia. Neurosci Lett 20:379-382
18. Koek W, Woods JH, Winger GD (1988) MK-801, a proposed non-competitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. J Pharmacol Exp Ther 245: 969-74
19. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers Jr MB, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199-214
20. Lahti AC, Koffel B, LaPorte D, Tamminga CA (1995) Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13:9-19
21. Lanning CF, Harmel MH (1975) Ketamine anesthesia. Annu Rev Med 26:137-141
22. MacIntosh KC (1973) Problems with ketamine anaesthesia. Br Med J 27:234
23. Madsen M, Lublin H (1998) MK-801-induced dystonia in Cebus monkeys. Clin Neuropharmacol 21:333-338
24. Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D, Breier A (1996) NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology 14:301-307
25. Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D, Breier A (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17:141-150
26. Moretti RJ, Hassan SZ, Goodman LI, Meltzer HY (1984) Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality. Anesth Analg 63:1087-1096
27. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998-1007
28. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244:1360-1362
29. Onoe H, Inoue O, Suzuki K, Tsukada H, Itoh T, Mataga N, Watanabe Y (1994) Ketamine increases the striatal N-[11C]methylspiperone binding in vivo: positron emission tomography study using conscious rhesus monkey. Brain Res 663:191-198
30. Pandit SK, Kothary SP, Kumar SM (1980) Low dose intravenous infusion technique with ketamine. Amnesic, analgesic and sedative effects in human volunteers. Anaesthesia 35:669-675
31. Sams-Dodd F (1996) Phencyclidine-induced stereotyped behaviour and social isolation in the rat: a possible animal model of schizophrenia. Behav Pharmacol 7:3-23
32. Schlemmer RF Jr, Jackson JA, Preston KL, Bederka JP Jr, Garver DL, Davis JM (1978) Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide. Eur J Pharmacol 52:379-384
33. Schorn TO, Witwam JG (1980) Are there long-term effects of ketamine on the central nervous system? Br J Anaesth 52:967-968
34. Swerdlow NR, Bakshi V, Waikar M, Taaid N, Geyer MA (1998) Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats. Psychopharmacology 140:75-80
35. Tiedtke PI, Bischoff C, Schmidt WJ (1990) MK-801-induced stereotypy and its antagonism by neuroleptic drugs. J Neural Transm 81:173-182
36. Wachtel RE (1988) Ketamine decreases the open time of single-channel currents activated by acetylcholine. Anesthesiology 68:563-570
37. Young AM, Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218: 720-727